首页> Current oncology (Toronto, Ont.)> Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study).

Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study).

导出 OA

翻译打印收藏纠错

第一作者： Elisa,Giommoni

第一单位： Medical Oncology Unit, Careggi University Hospital, 50134 Florence, Italy.

作者： Elisa,Giommoni ^[1] ; Evaristo,Maiello ^[2] ; Vanja,Vaccaro ^[3] ; Ermanno,Rondini ^[4] ; Caterina,Vivaldi ^[5] ; Giampaolo,Tortora ^[6] ; Laura,Toppo ^[7] ; Guido,Giordano ^[8] ; Tiziana Pia,Latiano ^[2] ; Cinzia,Lamperini ^[1] ; Serena,Pillozzi ^[1] ; Luca,Boni ^[9] ; Lorenzo,Antonuzzo ^[1] ; Francesco,Di Costanzo ^[1]

作者单位： Medical Oncology Unit, Careggi University Hospital, 50134 Florence, Italy. ^[1] Medical Oncology Unit, IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy. ^[2] Medical Oncology Unit, Istituto Nazionale Tumori Regina Elena, 00144 Roma, Italy. ^[3] Oncology Unit, Ospedale Santa Maria Nuova-IRCCS, 42100 Reggio Emilia, Italy. ^[4] Medical Oncology Unit 2, Azienda Ospedaliero Universitaria Pisana, 56126 Pisa, Italy. ^[5] Medical Oncology Unit, Azienda Ospedaliera Universitaria Integrata, 37134 Verona, Italy. ^[6] Medical Oncology Unit, ASST Cremona, 26100 Cremona, Italy. ^[7] Oncology Unit, Ospedale "Sacro Cuore di Gesù" Fatebenefratelli, 82100 Benevento, Italy. ^[8] Clinical Trial Coordinating Center, Careggi University Hospital, 50134 Florence, Italy. ^[9]

关键词 FOLFIRINOX dose finding metastatic pancreatic cancer nab-paclitaxel

医学主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);脱氧胞苷(Deoxycytidine);人类(Humans);胰腺肿瘤(Pancreatic Neoplasms)

DOI 10.3390/curroncol28030164

PMID 34066784

发布时间 2021-09-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交